Literature DB >> 27627867

Rheumatoid arthritis: Autoantibody testing to predict response to therapy in RA.

Leendert A Trouw1, Rene E M Toes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27627867     DOI： 10.1038/nrrheum.2016.151

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.

Authors:  Jing Shi; Rachel Knevel; Parawee Suwannalai; Michael P van der Linden; George M C Janssen; Peter A van Veelen; Nivine E W Levarht; Annette H M van der Helm-van Mil; Anthony Cerami; Tom W J Huizinga; Rene E M Toes; Leendert A Trouw
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

2.  The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis.

Authors:  Diane van der Woude; Silje W Syversen; Ellen I H van der Voort; Kirsten N Verpoort; Guro L Goll; Michael P M van der Linden; Annette H M van der Helm-van Mil; Désirée M F M van der Heijde; Tom W J Huizinga; Tore K Kvien; René E M Toes
Journal:  Ann Rheum Dis       Date:  2010-05-03       Impact factor: 19.103

3.  Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.

Authors:  Camille P Figueiredo; Holger Bang; Jayme Fogagnolo Cobra; Matthias Englbrecht; Axel J Hueber; Judith Haschka; Bernhard Manger; Arnd Kleyer; Michaela Reiser; Stephanie Finzel; Hans-Peter Tony; Stefan Kleinert; Joerg Wendler; Florian Schuch; Monika Ronneberger; Martin Feuchtenberger; Martin Fleck; Karin Manger; Wolfgang Ochs; Matthias Schmitt-Haendle; Hanns-Martin Lorenz; Hubert Nuesslein; Rieke Alten; Joerg Henes; Klaus Krueger; Jürgen Rech; Georg Schett
Journal:  Ann Rheum Dis       Date:  2016-06-20       Impact factor: 19.103

4.  Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial.

Authors:  Iris M Markusse; Gülsah Akdemir; Linda Dirven; Yvonne P M Goekoop-Ruiterman; Johannes H L M van Groenendael; K Huub Han; T H Esmeralda Molenaar; Saskia Le Cessie; Willem F Lems; Peter A H M van der Lubbe; Pit J S M Kerstens; André J Peeters; H Karel Ronday; Peter B J de Sonnaville; Irene Speyer; Theo Stijnen; Saskia Ten Wolde; Tom W J Huizinga; Cornelia F Allaart
Journal:  Ann Intern Med       Date:  2016-03-01       Impact factor: 25.391

Review 5.  The influence of ACPA status and characteristics on the course of RA.

Authors:  Annemiek Willemze; Leendert A Trouw; René E M Toes; Tom W J Huizinga
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

6.  Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis.

Authors:  John D Isaacs; Stanley B Cohen; Paul Emery; Paul P Tak; Jianmei Wang; Guiyuan Lei; Sarah Williams; Preeti Lal; Simon J Read
Journal:  Ann Rheum Dis       Date:  2012-06-11       Impact factor: 19.103

7.  Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.

Authors:  Geoffrey M Thiele; Michael J Duryee; Daniel R Anderson; Lynell W Klassen; Stephen M Mohring; Kathleen A Young; Dathe Benissan-Messan; Harlan Sayles; Anand Dusad; Carlos D Hunter; Jeremy Sokolove; William H Robinson; James R O'Dell; Anthony P Nicholas; Dean J Tuma; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

8.  Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.

Authors:  Diane van der Woude; Adam Young; Keeranur Jayakumar; Bart J Mertens; René E M Toes; Désirée van der Heijde; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  Arthritis Rheum       Date:  2009-08

9.  Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis.

Authors:  Maria Juarez; Holger Bang; Friederike Hammar; Ulf Reimer; Bernard Dyke; Ilfita Sahbudin; Christopher D Buckley; Benjamin Fisher; Andrew Filer; Karim Raza
Journal:  Ann Rheum Dis       Date:  2015-07-09       Impact factor: 19.103

10.  Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial.

Authors:  Jeremy Sokolove; Michael Schiff; Roy Fleischmann; Michael E Weinblatt; Sean E Connolly; Alyssa Johnsen; Jin Zhu; Michael A Maldonado; Salil Patel; William H Robinson
Journal:  Ann Rheum Dis       Date:  2015-09-10       Impact factor: 19.103
  10 in total
  2 in total

Review 1.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

2.  Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.

Authors:  Daniela Sieghart; Alexander Platzer; Paul Studenic; Farideh Alasti; Maresa Grundhuber; Sascha Swiniarski; Thomas Horn; Helmuth Haslacher; Stephan Blüml; Josef Smolen; Günter Steiner
Journal:  Front Immunol       Date:  2018-04-24       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.